Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Trillo MA et al. | 2013 | intact cell/cell culture, NB69 cells (neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 10–100 µT |
Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
Lee HJ et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Saffer JD et al. | 1997 | intact cell/cell culture, JB6 cell line (BALB/c mouse normal epithelial cells) | magnetic field, 50/60 Hz | 10 µT–1.1 mT |
Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
Destefanis M et al. | 2015 | intact cell/cell culture, SKBR3 (human breast cancer cells), GTL16 (human gastric cancer cells), HT29 (human colon cancer cells), A375P (human melanoma cells) | magnetic field, 50/60 Hz | 12 µT |
Raskmark P et al. | 1996 | intact cell/cell culture, transformed human epithelial amnion cells (AMA) | magnetic field, 50/60 Hz | 20–50 µT |
Supino R et al. | 2001 | intact cell/cell culture, MCF-7 (breast cancer cell line) and normal fibroblasts | magnetic field, 50/60 Hz | 20–500 µT |
Cridland NA et al. | 1996 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz, power transmission line | 20 µT–20 mT |
Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.